Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A new addition to the ranks
March 2019
SHARING OPTIONS:

BOSTON—resTORbio Inc. expanded its management team last month with the addition of Dr. Erkan Baloglu, who will serve as the company’s vice president of Drug Discovery and Medicinal Chemistry. Baloglu has more than 18 years of experience in advancing drug discovery programs, and previously served at Karyopharm Therapeutics as executive director of discovery and product leadership, with positions at GlaxoSmithKline, Epix Pharmaceuticals, Idenix Pharmaceuticals, ImmunoGen and Inotek Pharmaceuticals as well.
 
“We are pleased to welcome Erkan to resTORbio, as we continue to expand our team in anticipation of building out our pipeline of novel therapeutics for the treatment of aging-related diseases,” said Chen Schor, resTORbio’s co-founder, president and CEO. “Erkan’s industry background in drug discovery and early clinical development make him the perfect candidate to lead our discovery efforts, which are focused on next-generation TORC1 inhibitors and other aging-related pathways.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.